Medicine pack check sheet

Source-linked reading points

• The 200 mg TEGRETOL standard oral tablet, 100/200/400 mg TEGRETOL-XR extended-release oral tablets and oral suspension containing 100 mg per 5 mL are separately listed product identities. A shared brand or generic name does not make them self-convertible, make-up interchangeable, combinable or substitutable by milligrams, tablets or millilitres.
• This label states that TEGRETOL-XR should be swallowed whole and must not be crushed or chewed. That wording applies only to this exact U.S. extended-release tablet; it does not give this webpage permission to split, crush, mix or substitute any other carbamazepine product, standard tablet, liquid or medicine. Actual handling must follow the current label, prescription and pharmacist/prescribing-team advice.
• The boxed warning states that people with ancestry in genetically at-risk populations should be screened for HLA-B*1502 before starting treatment. This does not mean everyone needs broad genetic testing, nor can a webpage infer an individual's ancestry, test choice, result meaning or whether to start, continue, pause or switch; the prescribing team, pharmacist or genetics professional must interpret the actual context.
• With a new or progressive rash, blistering, mouth sores, fever, facial swelling, jaundice-like changes, marked drowsiness/mental-status change, fainting or another acute concern, contact local medical support promptly. Do not self-make-up, increase, abruptly stop or change to another product from this webpage because of an adverse-effect concern.